Genmab A/S (FRA:GE9)

Genmab Revenue

Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 25.25% growth. This brings the company's revenue in the last twelve months to $3.47B, up 16.96% year-over-year. In the year 2024, Genmab had annual revenue of $3.00B with 23.13% growth.

• Revenue (ttm): $3.47B
• Revenue Growth: +16.96%
• P/S Ratio: 5.49
• Revenue / Employee: $1.29M
• Employees: 2,682
• Market Cap: 17.99B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.00B	564.17M	23.13%
Dec 31, 2023	2.44B	351.45M	16.83%
Dec 31, 2022	2.09B	800.56M	62.19%
Dec 31, 2021	1.29B	-372.56M	-22.45%
Dec 31, 2020	1.66B	854.43M	106.10%
Dec 31, 2019	805.32M	340.75M	73.35%
Dec 31, 2018	464.57M	83.37M	21.87%
Dec 31, 2017	381.20M	-144.81M	-27.53%
Dec 31, 2016	526.01M	195.32M	59.07%
Dec 31, 2015	330.68M	-	-